[2] LIN X, XU Y, PAN X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025[J]. Sci Rep,2020,10(1): 14790.
[3] WANG L, GAO P, ZHANG M, et al.Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013[J].JAMA,2017,317(24): 2515-2523.
[4] BRAGG F, HOLMES M V, IONA A, et al. Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China[J].JAMA,2017,317(3): 280-289.
[5] POLICARDO L, SEGHIERI G, ANICHINI R, et al. Effect of diabetes on hospitalization for ischemic stroke and related in-hospital mortality: a study in Tuscany, Italy, over years 2004-2011[J].Diabetes Metab Res Rev,.2015,31(3): 280-286.
[6] COLE J B, FLOREZ J C. Genetics of diabetes mellitus and diabetes complications[J].Nat Rev Nephrol,2020,16(7): 377-390.
[7] CHO N H, SHAW J E, KARURANGA S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018(138): 271-281.
[8] SELLAMI R, MASMOUDI J, OUALI U, et al. The relationship between alopecia areata and alexithymia, anxiety and depression: A case-control study[J]. Indian J Dermatol, 2014,59(4):421-421.
[10] XINGQI Z, MEI Y, WAYNE Y, et al. Development of alopecia areata is associated with higher central and peripheral hypothalamic-pituitary-adrenal tone in the skin graft induced C3H/HeJ mouse model[J]. J Invest Dermatol, 2009,129(6):1527-1538
[22] HUANG S, MU F, LI F, et al. A Network-Based Approach to Explore the Mechanism and Bioactive Compounds of Erzhi Pill against Metabolic Dysfunction-Associated Fatty Liver Disease[J].J Diabetes Res,2020,2020: 1-15.
[27] LIM S, JANG H J, PARK E H, et al. Wedelolactone inhibits adipogenesis through the ERK pathway in human adipose tissue-derived mesenchymal stem cells[J].J Cell Biochem,2012,113(11): 3436-3445.
[28] ZHUANG Z J, SHAN C W, LI B, et al. Linarin Enriched Extract Attenuates Liver Injury and Inflammation Induced by High-Fat High-Cholesterol Diet in Rats[J].Evid Based Complement Alternat Med,2017, 2017(2017): 1-9.
[29] CHEN S, JIANG H, WU X, et al. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes[J].Mediators Inflamm,2016, 2016(3): 1-5.
[30] SUNIL C, XU B. An insight into the health-promoting effects of taxifolin (dihydroquercetin)[J].Phytochemistry,2019, 2019(166): 112066.
[31] TANAKA M, SAITO S, INOUE T, et al. Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future Perspectives[J].Int J Mol Sci,2019, 20(9) : 2139.
[32] ALWHAIBI A, VERMA A, ADIL M S, et al. The unconventional role of Akt1 in the advanced cancers and in diabetes-promoted carcinogenesis[J].Pharmacol Res, 2019, 2019(145): 104270.
[33] KAZI J U, RöNNSTRAND L. The role of SRC family kinases in FLT3 signaling[J].Int J Biochem Cell Biol,2019, 2018(107): 32-37.
[34] BALDASSARRE G, BELLETTI B. Meet me in the cytoplasm: A role for p27(Kip1) in the control of H-Ras[J].Small GTPases,2016. 7(2): 71-75.
[35] SINGH D, ATTRI B K, GILL R K, et al. Review on EGFR Inhibitors: Critical Updates[J].Mini Rev Med Chem,2016,16(14): 1134-1166.
[36] VENOT Q, CANAUD G. [PIK3CA-related overgrowth syndrome (PROS)][J].Nephrol Ther,2017,2017(13): S155-S156.
[37] YU H, PARDOLL D, JOVE R. STATs in cancer inflammation and immunity: a leading role for STAT3[J].Nat Rev Cancer,2009,9(11): 798-809.
[38] MEHTA A K, GRACIAS D T, CROFT M. TNF activity and T cells[J].Cytokine,2018,2018(101): 14-18.
[39] HUMPHREY S J, JAMES D E, MANN M. Protein Phosphorylation: A Major Switch Mechanism for Metabolic Regulation[J].Trends Endocrinol Metab,2015,26(12): 676-687.
[40] FREEMAN M E, KANYICSKA B, LERANT A, et al. Prolactin: structure, function, and regulation of secretion[J].Physiol Rev,2000,80(4): 1523-1631.
[41] BORBA V V, ZANDMAN-GODDARD G, SHOENFELD Y. Prolactin and Autoimmunity[J]. Front Immunol,2018, 9(73): 1-8.
[42] BERNARD V, YOUNG J, BINART N. Prolactin - a pleiotropic factor in health and disease[J].Nat Rev Endocrinol,2019,15(6): 356-365.
[43] ZHEN Z,LI Y,JINHUA Y,et al.PI3K/Akt and HIF-1 signaling pathway in hypoxia-ischemia (Review)[J].Mol Med Rep,2018,18(4):3547-3554.
[44] STEFANINI L, BERGMEIER W. RAP1-GTPase signaling and platelet function[J].J Mol Med (Berl),2016,94(1): 13-19.
[45] TEBAR F, ENRICH C, RENTERO C, et al. GTPases Rac1 and Ras Signaling from Endosomes[J].Prog Mol Subcell Biol,2018,2018(57): 65-105.